Stethoscope and medical billAmericans would rather see Congress prioritize tackling issues suchas drug prices, pre-existing conditions and surprise medical billsthan undertake another  major health care reform.

A poll from the Kaiser Family Foundation (KFF) shows that mostAmericans want the Affordable Care Act (ACA) to continue to be thelaw of the land—and that they are focused more on specific issuesof health care, such as high drug costs, rather than wanting to seesweeping changes like creating a Medicare for All system.

The April tracking poll from KFF shows thatAmericans are very concerned about health care issues that couldaffect them directly. When asked what priorities Congress shouldhave regarding health care policy:

  • 68 percent of Americans saying lowering drug costs should be a toppriority
  • 64 percent list protections for people with pre-existing healthconditions as a top priority
  • 50 percent say protecting people from surprise medical billsshould be a top priority

On the other hand, implementing a Medicare for All system islisted as a top priority for 31 percent of Americans; repealing andreplacing the ACA is listed by 27 percent; and expanding financialhelp for those already on the ACA marketplace is listed as a toppriority by 26 percent of respondents.

Medicare for All has support—depending on how it's defined

Even if it's not top-of-mind for Americans, the Medicare for Allconcept has had steady support in recent years. In the most recentpolling, 56 percent of Americans said they favor a Medicare for allsystem. Support for the concept has remained steady, at between 59percent and 55 percent in KFF polls since June 2017.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.